Free Alerts   Login
Health Care › Electromedical And Electrotherapeutic Apparatus

AXGN Stock Price Correlated With Axogen Financials

AXGN Stock Price vs. Quarterly
AXGN
Income Statement
Cash Flow
Balance Sheet

AXGN Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

AXGN Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

AXGN Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Arrowmark Colorado Holdings
5,152,300 sh
597,420 sh
13%
$35,190
$12,416
Blackrock.
3,342,773 sh
98,329 sh
3%
$22,831
$6,609
Morgan Stanley
3,082,437 sh
2,702,067 sh
710%
$21,052
$19,149
Soleus Capital Management, L.P.
2,595,815 sh
805,817 sh
45%
$17,729
$1,386
Vanguard Group
2,465,496 sh
-13,025 sh
-1%
$16,839
$4,447
Millennium Management
1,488,720 sh
-104,543 sh
-7%
$10,168
$2,202
Dafna Capital Management
935,894 sh
 
$6,392
Geode Capital Management
896,336 sh
47,593 sh
6%
$6,123
$1,879
Perceptive Advisors
808,380 sh
-67,518 sh
-8%
$5,521
$1,142
State Street
792,087 sh
29,749 sh
4%
$5,410
$1,598
Tocqueville Asset Management L.P.
769,900 sh
-165,000 sh
-18%
$5,258
$583
Silvercrest Asset Management Group
756,248 sh
-165,738 sh
-18%
$5,165
$555
D. E. Shaw & Co..
610,988 sh
35,543 sh
6%
$4,173
$1,296
Dimensional Fund Advisors
579,266 sh
-24,877 sh
-4%
$3,956
$935
Deutsche Bank Ag\
578,640 sh
552,999 sh
2157%
$3,952
$3,824
Bank Of America /De/
521,715 sh
-1,195,457 sh
-70%
$3,564
-$5,022
Goldman Sachs Group
509,214 sh
435,481 sh
591%
$3,478
$3,109
Northernrp
382,292 sh
-24,292 sh
-6%
$2,611
$578
Nuveen Asset Management
353,136 sh
165,310 sh
88%
$2,411
$1,472
Charles Schwab Investment Management
331,313 sh
21,237 sh
7%
$2,263
$713
COMPANY PROFILE
1. Basis of Presentation
The accompanying condensed consolidated financial statements include the accounts of AxoGen, Inc. (the “Company” or
“AxoGen”) and its wholly owned subsidiary AxoGen Corporation (“AC”) as of March 31, 2012 and December 31, 2011 and for the three month periods ended March 31, 2012 and 2011. The Company’s condensed
consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and should be read in conjunction with the audited financial statements of the Company for the year
ended December 31, 2011, which are included in the Annual Report on Form 10-K for the year ended December 31, 2011. The interim condensed consolidated financial statements are unaudited and in the opinion of management, reflect all
adjustments necessary for a fair presentation of results for the periods presented. Results for interim periods are not necessarily indicative of results for the full year. All significant intercompany accounts and transactions have been eliminated
in consolidation. In October 2011, the Company moved its corporate headquarter facilities (principal executive office) from Texarkana, Texas to 13859 Progress Blvd., Suite 100, Alachua, Florida 32615.

Free historical financial statements for Axogen Inc. See how revenue, income, cash flow, and balance sheet financials have changed over 48 quarters since 2012. Compare with AXGN stock chart to see long term trends.

Data imported from Axogen Inc SEC filings. Check original filings before making any investment decision.